These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3875449)

  • 21. A comparison of primary versus secondary cardiovascular disease prevention in an academic family practice.
    Eaton CB; McQuade W; Glupczynski D
    Fam Med; 1994 Oct; 26(9):587-92. PubMed ID: 7843510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cardiovascular prevention: new study, new guidelines. The effort keeping the heart healthy].
    Einecke D
    MMW Fortschr Med; 2004 Sep; 146(38):4-6, 8. PubMed ID: 15532422
    [No Abstract]   [Full Text] [Related]  

  • 23. JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice.
    ; ; ; ; ;
    Heart; 2005 Dec; 91 Suppl 5(Suppl 5):v1-52. PubMed ID: 16365341
    [No Abstract]   [Full Text] [Related]  

  • 24. [Development of cooperative research programs in the epidemiology and prevention of ischemic heart disease and arterial hypertension].
    Oganov RG
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1983; 6(1):3-7. PubMed ID: 6860470
    [No Abstract]   [Full Text] [Related]  

  • 25. [Community control of cardiovascular diseases in Beijing].
    Wu YK; Yu JS; Yu MC; Lu CQ; Gao RQ; He GQ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1982; 4(2):105-8. PubMed ID: 6216004
    [No Abstract]   [Full Text] [Related]  

  • 26. [Cardiovascular diseases, medical apocalypse of the 21st century?].
    Mielnik M; Steciwko A
    Przegl Lek; 2004; 61(3):159-64. PubMed ID: 15518325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A new effective cardiovascular therapy option. Prescribe sports!].
    Bischoff A
    MMW Fortschr Med; 2008 Mar; 150(12):16. PubMed ID: 18533589
    [No Abstract]   [Full Text] [Related]  

  • 28. [Current status and prospects of the prevention and control of cardiovascular diseases].
    Gu DF
    Zhonghua Yu Fang Yi Xue Za Zhi; 2003 Mar; 37(2):75-6. PubMed ID: 15376371
    [No Abstract]   [Full Text] [Related]  

  • 29. Cardiovascular risk reduction. The problems facing our society.
    Harrison DC; Winston M
    Health Educ; 1982; 13(1):9-12. PubMed ID: 6799459
    [No Abstract]   [Full Text] [Related]  

  • 30. [The PreFord Study. A prospective cohort study to evaluate the risk of a cardiovascular event (overall-collective) as well as a prospective, randomized, controlled, multicentre clinical intervention study (high-risk-collective) on primary prevention of cardiovascular diseases in the Ford Motor Company employees in Germany].
    Gysan DB; Latsch J; Bjarnason-Wehrens B; Albus C; Falkowski G; Herold G; Mey E; Heinzler R; Montiel G; Schneider CA; Stützer H; Türk S; Weisbrod M; Predel HG
    Z Kardiol; 2004 Feb; 93(2):131-6. PubMed ID: 14963679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cohort profile: the Asia Pacific Cohort Studies Collaboration.
    Woodward M; Barzi F; Martiniuk A; Fang X; Gu DF; Imai Y; Lam TH; Pan WH; Rodgers A; Suh I; Jee SH; Ueshima H; Huxley R;
    Int J Epidemiol; 2006 Dec; 35(6):1412-6. PubMed ID: 17060333
    [No Abstract]   [Full Text] [Related]  

  • 32. Physical fitness and physical activity at age 13 years as predictors of cardiovascular disease risk factors at ages 15, 25, 33, and 40 years: extended follow-up of the Oslo Youth Study.
    Kvaavik E; Klepp KI; Tell GS; Meyer HE; Batty GD
    Pediatrics; 2009 Jan; 123(1):e80-6. PubMed ID: 19117851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in cardiovascular epidemiology since 1950.
    Feinleib M
    Bull N Y Acad Med; 1984 Jun; 60(5):449-64. PubMed ID: 6587924
    [No Abstract]   [Full Text] [Related]  

  • 34. The estimate of cardiovascular risk. Theory, tools and problems.
    Menotti A; Puddu PE; Lanti M
    Ann Ital Med Int; 2002; 17(2):81-94. PubMed ID: 12150050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Significance and value of epidemiologic studies for assessing the effectiveness of measures in primary prevention].
    Knappe J; Hahn W
    Z Arztl Fortbild (Jena); 1989; 83(21):1043-5. PubMed ID: 2631452
    [No Abstract]   [Full Text] [Related]  

  • 36. [Factors of cardiovascular risk for hypertensive patients followed during primary care].
    Ben Abdelaziz A; Elrafei W; Gaha K; Mandhouj O; Ben Othman A; Ghannem H
    Tunis Med; 2008 Jul; 86(7):643-8. PubMed ID: 19472724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A five-year report (1975-1979) of a cardiovascular community control program in the Shijingshan District of Beijing.
    Wu YK; Yu JS; Yu MZ; Lu CQ; Gao RQ; He GQ
    Chin Med J (Engl); 1982 Mar; 95(3):163-6. PubMed ID: 6807622
    [No Abstract]   [Full Text] [Related]  

  • 38. Is the decrease of cardiovascular mortality in Poland associated with the reduction of global cardiovascular risk related to changes in life style?
    Rywik SL; Piotrowski W; Rywik TM; Broda G; Szcześniewska D
    Kardiol Pol; 2003 May; 58(5):344-55; discussion: 355. PubMed ID: 14523482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A five year report on community control of hypertension, stroke and coronary heart disease in the Shijingshan People's Commune, Beijing.
    Wu YK; Yu JS; Lu CQ; Wu ZS; Chen YF; Yu MZ
    Chin Med J (Engl); 1981 Apr; 94(4):233-6. PubMed ID: 6790238
    [No Abstract]   [Full Text] [Related]  

  • 40. Control of hypertension in patients at high risk of cardiovascular disease.
    Roca B; Suárez C; Ceballos A; Varela JM; Nonell F; Montes J; Sobrino J; de la Peña A;
    QJM; 2005 Aug; 98(8):581-8. PubMed ID: 15983023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.